Skip to main content
. 2014 May 22;6(4):287–294. doi: 10.14740/jocmr1841e

Table 1. Changes of Glycemic and Non-Glycemic Parameters With Teneligliptin .

Baseline 3 months P values
Age 58.29 ± 14.95
HbA1c (%NGSP) 10.34 ± 2.06 8.38 ± 2.23 < 0.00001
FBG (mg/dL) 211.3 ± 68.4 167.3 ± 70.2 < 0.0002
Insulin (μU/mL) 7.68 ± 9.24 7.55 ± 5.15 n.s.
HOMA-R 3.74 ± 4.28 2.90 ± 2.16 n.s.
HOMA-B 24.04 ± 31.14 40.23 ± 40.98 < 0.00001
T-C (mg/dL) 218.3 ± 33.4 217.2 ± 38.9 n.s.
TG (mg/dL) 126.7 ± 46.8 128.0 ± 66.4 n.s.
HDL-C (mg/dL) 56.4 ± 15.4 57.2 ± 15.9 n.s.
Non-HDL-C (mg/dL) 161.8 ± 32.3 159.9 ± 39.0 n.s.
LDL-C (mg/dL) 140.2 ± 30.9 141.1 ± 32.7 n.s.
FFA (mEq/dL) 0.754 ± 0.361 0.676 ± 0.253 n.s.
UA (mg/dL) 4.69 ± 1.41 5.15 ± 1.55 < 0.05
BMI 23.90 ± 4.61 23.90 ± 3.99 n.s.

Paired Student’s t-test was used to compare the changes of the indicated parameters before and after treatment. The results are expressed as the mean ± SD.